ADC定量对同步放化疗宫颈癌临床结局的预后价值
纳入124例接受根治性同步放化疗的宫颈癌患者,治疗前及治疗开始后1个月行3T-MRI测量肿瘤平均ADC值并计算ΔADCmean。多因素分析显示ΔADCmean是PFS、CSS和OS的唯一独立预测因子,ΔADCmean低于阈值者生存显著更差。
要点
- 治疗前与治疗开始后1个月肿瘤平均ADC值的百分比变化(ΔADCmean)是PFS、CSS和OS的独立预测因子。
- ΔADCmean<27.8%者PFS显著更低(p=0.001),ΔADCmean<16.1%者CSS和OS显著更低(p=0.002和p<0.001)。
- 鳞状细胞癌抗原、组织学类型和治疗前肿瘤大小是PFS的显著独立预测因子。
核心结论
- 肿瘤ADC的百分比变化可能是有用的预测指标,用于预测接受同步放化疗的宫颈癌患者的疾病进展和生存。
研究设计与样本
- 纳入124例接受根治性同步放化疗的宫颈癌患者,在治疗前和治疗开始后1个月行3T-MRI检查,测量肿瘤平均ADC值并计算ΔADCmean,采用Cox比例风险模型评估影像或临床变量与PFS、CSS和OS的关联。
关键影像表现/征象
- 在肿瘤上测量平均ADC值,并计算两个时间点之间的ADC百分比变化(ΔADCmean)。
- ΔADCmean是PFS的唯一独立预测因子(HR=0.2379,p=0.005)。
- ΔADCmean是CSS的唯一独立预测因子(HR=0.310,p=0.024)。
- ΔADCmean是OS的唯一独立预测因子(HR=0.217,p=0.002)。
诊断标准与关键数值
- ΔADCmean<27.8%者PFS显著更低(p=0.001)。
- ΔADCmean<16.1%者CSS显著更低(p=0.002)。
- ΔADCmean<16.1%者OS显著更低(p<0.001)。
- ΔADCmean≥cutoff值者生存优于ΔADCmean<cutoff值者。
临床应用与阅片要点
- DWI被广泛用作肿瘤活力的潜在标志物。
- 肿瘤ADC的百分比变化(ΔADCmean)是PFS、CSS和OS的独立标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the prognostic value of diffusion-weighted imaging (DWI) in predicting clinical outcome in patients with cervical cancer after concurrent chemoradiotherapy (CCRT).
METHODS: We enrolled 124 cervical cancer patients who received definitive CCRT and underwent 3 T-MRI before and 1 month after initiating treatment. The mean apparent diffusion coefficient (ADC) value was measured on the tumor and the changes in ADC percentage (ΔADCmean) between the two time points were calculated. The Cox proportion hazard model was used to evaluate the associations between imaging or clinical variables and progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS).
RESULTS: In multivariate analysis, ΔADCmean was the only independent predictor of PFS (hazard ratio [HR] = 0.2379, p = 0.005), CSS (HR = 0.310, p = 0.024), and OS (HR = 0.217, p = 0.002). Squamous cell carcinoma antigen, histology, and pretreatment tumor size were significantly independent predictors of PFS. Tumor size response was significantly independent predictor of CSS and OS. Using the cutoff values of ΔADCmean, the PFS was significantly lower for ΔADCmean < 27.8% (p = 0.001). The CSS and OS were significantly lower for ΔADCmean < 16.1% (p = 0.002 and p < 0.001, respectively).
CONCLUSION: The percentage change in tumor ADC may be a useful predictor of disease progression and survival in patients with cervical cancer treated with CCRT.
KEY POINTS: • DWI is widely used as a potential marker of tumor viability. • Percentage change in tumor ADC (ΔADC mean ) was an independent marker of PFS, CSS, and OS. • Survival was better in patients with ≥ ΔADC mean cutoff value than with < the cutoff value.
引用
- Gu KW, Kim CK, Choi CH, et al. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy. Eur Radiol. 2019. PMID: 30980126. doi:10.1007/s00330-019-06204-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。